Table: Kringle Pharma - Q1 parent results

Kringle Pharma

09/02/2024 06:40

Feb 9 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Dec 31, 2023        Dec 31, 2022       Sep 30, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            18 mln              17 mln            272 mln     
                 (+7.6 pct)          (+25.8 pct)       (+292.8 pct)  
  Operating     loss 168 mln        loss 157 mln        loss 1.13    
  Recurring     loss 169 mln        loss 157 mln        loss 1.11    
  Net           loss 169 mln        loss 157 mln        loss 1.11    
  EPS          loss 29.53 yen      loss 29.34 yen    loss 180.12 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T